Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > RT30 Retatrutide 30mg (RT30) Lyophilized Peptide
RT30 Retatrutide 30mg (RT30) Lyophilized Peptide buy - large image1
RT30 Retatrutide 30mg (RT30) Lyophilized Peptide buy - image1
RT30 Retatrutide 30mg (RT30) Lyophilized Peptide buy - image2
RT30 Retatrutide 30mg (RT30) Lyophilized Peptide buy - image3
RT30 Retatrutide 30mg (RT30) Lyophilized Peptide buy - image4

RT30 Retatrutide 30mg (RT30) Lyophilized Peptide

TDS 6861 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHENGZHEN

Brand:

KSD

Packaging:

30mg/box

Price valid (until):

2026-09-06

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Contact Us 


    • Name:Chloe
    • WeChat and WhatApps:+852 6732 2979
    • Emails:3524465053@qq.com
    • Product Introduction:
    • RT30 is research‑grade Retatrutide (LY‑3437943), supplied as 30mg per vial. Retatrutide is a triple‑receptor agonist that activates GLP‑1, GIP and glucagon receptors simultaneously, widely studied for metabolic‑related laboratory research.

      The product appears as white to off‑white lyophilized cake powder, HPLC purity ≥99%. Each batch comes with complete COA documentation. Store lyophilized powder at ‑20℃, away from light and moisture. After reconstitution, it forms clear colorless solution.




    Items Specifications
    Product Name RT30 (Retatrutide 30mg/vial, GLP3-RT, LY-3437943)
    Appearance White to off-white lyophilized cake powder
    HPLC Purity ≥99.0%
    Molecular Formula C₂₂₁H₃₄₂N₄₆O₆₈
    Molecular Weight 4731.33
    Reconstitution Property Forms clear & colorless solution after dissolving with qualified solvent
    Storage Condition Lyophilized powder stored at -20℃, sealed, avoid light & moisture


      Product Features  


    1.Triple Target Agonist
    Targets GLP‑1, GIP and GCGR receptors simultaneously, core research material for metabolic related laboratory study.
    2.High Purity Standard
    HPLC tested purity ≥99.0%, low impurity content, stable experimental repeatability for research trials.
    3.Complete Identity Confirmation
    Unique CAS No.2381089‑83‑2, matched molecular formula & weight, identifiable with standard testing methods.
    4.Stable Lyophilized Form
    White/off‑white freeze‑dried cake powder, effectively avoids degradation and oxidation during long‑term storage.
    5.Good Reconstitution Performance
    Dissolves rapidly in suitable solvent to form clear, colorless particle‑free solution without clouding or gelation.
    6.Standardized Packaging Specification
    Fixed 30mg per vial independent packaging, convenient for accurate dosing allocation in lab experiments.
    7.Rigorous Batch Traceability
    Each batch accompanied with full COA report covering purity, moisture, residual solvent and related inspection items.
    8.Long Shelf Life Under Proper Storage
    Lyophilized powder stored at -20℃ away from light & moisture, retains stable activity for long‑term reserve use.



      Product Images


    Shop RT30 Retatrutide 30mg (RT30) Lyophilized Peptide-Detailed Image 1


    How to Order  


    Shop RT30 Retatrutide 30mg (RT30) Lyophilized Peptide-Detailed Image 2


     Why  Choose Us


    1.High quality products with competitive pricing.


    2.Free samples available for your evaluation and testing.


    3.Fast, reliable delivery via reputable shipping lines.


    4.Trial orders are welcome for quality verification after sample approval.


    5.Proactive updates and full transparency at every stage of your order.



    Company Profile 


    Shop RT30 Retatrutide 30mg (RT30) Lyophilized Peptide-Detailed Image 3


      FAQ 


    1. Q: What are your production cycle and delivery time?
    A: For regular in-stock peptide products, the production cycle is 3 to 7 working days. We ship entirely by air, with a total transportation cycle of 10 to 14 working days after delivery. Ample stock ensures a long-term, stable, and uninterrupted supply.

    2. Q: What are your main export markets?

    A: Our products are sold worldwide, including the United States, Canada, Australia, the Netherlands, New Zealand, Italy, France, Germany, Mexico, and many other countries and regions.

    3. Q: What customer service and after-sales support do you provide?


    A: We provide comprehensive customer service throughout the entire process. If you encounter problems with product quality, air freight damage, shipping documents, or product usage guidelines, our team will respond quickly and provide practical solutions to fully protect your legal rights.

    4. Q: How is the quality of your products?

    A: Each batch of products undergoes rigorous quality inspection before delivery to ensure HPLC purity is above 99%. Complete inspection documents, such as product certificates and HPLC reports, will be provided for your reference.

    5. Q: What shipping methods do you use?

    A: We use professional air freight for all peptide shipments, combined with cold chain packaging, to ensure the activity and stability of the peptides during transportation.

    6. Q: What payment methods are available for orders?

    A: We support Alipay, Bitcoin, and USDT for your selection.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide

    Location:

    Licheng District, Jinan City, Shandong Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

    Certifications:

    Retatrutide coa

    Hello and welcome to learn about Kangshengda Biotechnology! We are a specialized enterprise dedicated to the R&D and production of peptide products. Leveraging high-quality peptide preparations, our core strength lies in supporting customers to achieve long-term weight management and all-round health regulation.
    Boasting extensive mature export experience, our products are sold to Europe, the United States and numerous other countries and regions worldwide. Supported by consistent, reliable product quality, efficient on-time delivery and a comprehensive professional after-sales service system, we have built long-term, solid strategic partnerships with overseas distributors.
    We are committed to delivering one-stop customized premium peptide solutions for all clients, and seek long-term development and win-win cooperation alongside domestic and global partners!
    KSD
    ">KSD
  • Inquiry History
    6861 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.